Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development Takeda Pharmaceutical
Mike Jones is Search & Evaluation Lead for GI & Inflammation within the Center for External Innovation at Takeda, where he focuses on identifying and assessing external opportunities across gastrointestinal and immune-mediated diseases. Prior to joining Takeda, Mike worked in healthcare strategy and consulting, including roles at ClearView Healthcare Partners, where he advised biopharma clients on portfolio, partnering, and development strategy, bringing a strong foundation in drug development and immunology to his current role
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion: Investing into Immune Rest, Rebalance & Reconstitution
8:40 am
- Which stage of development is most appealing in Immunology?
- What are the starting points, from a data package perspective, when it comes to assessing engagers or in vivo CAR-T?
- When evaluating an early-stage what level of data—whether safety, biomarkers, or efficacy—provides you with conviction that the program has true drug potential?
- Which diseases do you think are most promising for B-cell targeted therapies?
